BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 16160621)

  • 1. Is the prophylactic antidepressant efficacy of lithium in bipolar I disorder dependent on study design and lithium level?
    Severus WE; Grunze H; Kleindienst N; Frangou S; Moeller HJ
    J Clin Psychopharmacol; 2005 Oct; 25(5):457-62. PubMed ID: 16160621
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently manic or hypomanic patients with bipolar I disorder.
    Bowden CL; Calabrese JR; Sachs G; Yatham LN; Asghar SA; Hompland M; Montgomery P; Earl N; Smoot TM; DeVeaugh-Geiss J;
    Arch Gen Psychiatry; 2003 Apr; 60(4):392-400. PubMed ID: 12695317
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lamotrigine compared to placebo and other agents with antidepressant activity in patients with unipolar and bipolar depression: a comprehensive meta-analysis of efficacy and safety outcomes in short-term trials.
    Solmi M; Veronese N; Zaninotto L; van der Loos ML; Gao K; Schaffer A; Reis C; Normann C; Anghelescu IG; Correll CU
    CNS Spectr; 2016 Oct; 21(5):403-418. PubMed ID: 27686028
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recurrence in bipolar I disorder: a post hoc analysis excluding relapses in two double-blind maintenance studies.
    Calabrese JR; Goldberg JF; Ketter TA; Suppes T; Frye M; White R; DeVeaugh-Geiss A; Thompson TR
    Biol Psychiatry; 2006 Jun; 59(11):1061-4. PubMed ID: 16769295
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently depressed patients with bipolar I disorder.
    Calabrese JR; Bowden CL; Sachs G; Yatham LN; Behnke K; Mehtonen OP; Montgomery P; Ascher J; Paska W; Earl N; DeVeaugh-Geiss J;
    J Clin Psychiatry; 2003 Sep; 64(9):1013-24. PubMed ID: 14628976
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A pooled analysis of 2 placebo-controlled 18-month trials of lamotrigine and lithium maintenance in bipolar I disorder.
    Goodwin GM; Bowden CL; Calabrese JR; Grunze H; Kasper S; White R; Greene P; Leadbetter R
    J Clin Psychiatry; 2004 Mar; 65(3):432-41. PubMed ID: 15096085
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The clinical usefulness of lithium as an antidepressant.
    Doyal LE; Morton WA
    Hosp Community Psychiatry; 1984 Jul; 35(7):685-91. PubMed ID: 6378754
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incidence and time course of subsyndromal symptoms in patients with bipolar I disorder: an evaluation of 2 placebo-controlled maintenance trials.
    Frye MA; Yatham LN; Calabrese JR; Bowden CL; Ketter TA; Suppes T; Adams BE; Thompson TR
    J Clin Psychiatry; 2006 Nov; 67(11):1721-8. PubMed ID: 17196051
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is the polarity of relapse/recurrence in bipolar-I disorder patients related to serum lithium levels? Results from an empirical study.
    Severus WE; Kleindienst N; Evoniuk G; Bowden C; Möller HJ; Bohus M; Frangou S; Greil W; Calabrese JR
    J Affect Disord; 2009 Jun; 115(3):466-70. PubMed ID: 19019453
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and safety of lithium and lamotrigine for the maintenance treatment of clinically stable patients with bipolar disorder: A systematic review and meta-analysis of double-blind, randomized, placebo-controlled trials with an enrichment design.
    Oya K; Sakuma K; Esumi S; Hashimoto Y; Hatano M; Matsuda Y; Matsui Y; Miyake N; Nomura I; Okuya M; Iwata N; Kato M; Hashimoto R; Mishima K; Watanabe N; Kishi T
    Neuropsychopharmacol Rep; 2019 Sep; 39(3):241-246. PubMed ID: 31026388
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term outcome of bipolar depressed patients receiving lamotrigine as add-on to lithium with the possibility of the addition of paroxetine in nonresponders: a randomized, placebo-controlled trial with a novel design.
    van der Loos ML; Mulder P; Hartong EG; Blom MB; Vergouwen AC; van Noorden MS; Timmermans MA; Vieta E; Nolen WA;
    Bipolar Disord; 2011 Feb; 13(1):111-7. PubMed ID: 21320258
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Maintenance therapies in bipolar disorder: focus on randomized controlled trials.
    Muzina DJ; Calabrese JR
    Aust N Z J Psychiatry; 2005 Aug; 39(8):652-61. PubMed ID: 16050919
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Valproic acid, valproate and divalproex in the maintenance treatment of bipolar disorder.
    Macritchie KA; Geddes JR; Scott J; Haslam DR; Goodwin GM
    Cochrane Database Syst Rev; 2001; (3):CD003196. PubMed ID: 11687047
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Olanzapine versus lithium in the maintenance treatment of bipolar disorder: a 12-month, randomized, double-blind, controlled clinical trial.
    Tohen M; Greil W; Calabrese JR; Sachs GS; Yatham LN; Oerlinghausen BM; Koukopoulos A; Cassano GB; Grunze H; Licht RW; Dell'Osso L; Evans AR; Risser R; Baker RW; Crane H; Dossenbach MR; Bowden CL
    Am J Psychiatry; 2005 Jul; 162(7):1281-90. PubMed ID: 15994710
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Depressive relapse during lithium treatment associated with increased serum thyroid-stimulating hormone: results from two placebo-controlled bipolar I maintenance studies.
    Frye MA; Yatham L; Ketter TA; Goldberg J; Suppes T; Calabrese JR; Bowden CL; Bourne E; Bahn RS; Adams B
    Acta Psychiatr Scand; 2009 Jul; 120(1):10-3. PubMed ID: 19183414
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The association of the effect of lithium in the maintenance treatment of bipolar disorder with lithium plasma levels: a post hoc analysis of a double-blind study comparing switching to lithium or placebo in patients who responded to quetiapine (Trial 144).
    Nolen WA; Weisler RH
    Bipolar Disord; 2013 Feb; 15(1):100-9. PubMed ID: 23228201
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antidepressant properties of anticonvulsant drugs for bipolar disorder.
    Ernst CL; Goldberg JF
    J Clin Psychopharmacol; 2003 Apr; 23(2):182-92. PubMed ID: 12640220
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and safety of lamotrigine as add-on treatment to lithium in bipolar depression: a multicenter, double-blind, placebo-controlled trial.
    van der Loos ML; Mulder PG; Hartong EG; Blom MB; Vergouwen AC; de Keyzer HJ; Notten PJ; Luteijn ML; Timmermans MA; Vieta E; Nolen WA;
    J Clin Psychiatry; 2009 Feb; 70(2):223-31. PubMed ID: 19200421
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bipolar disorder therapeutics: maintenance treatment.
    Sachs GS; Thase ME
    Biol Psychiatry; 2000 Sep; 48(6):573-81. PubMed ID: 11018228
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The early European lithium studies.
    Schou M
    Aust N Z J Psychiatry; 1999 Dec; 33 Suppl():S39-47. PubMed ID: 10622179
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.